MARKET

CNSP

CNSP

CNS Pharmaceuticals
NASDAQ
5.73
-0.16
-2.66%
Closed 19:30 09/04 EDT
OPEN
5.86
PREV CLOSE
5.89
HIGH
5.92
LOW
5.73
VOLUME
4.81K
TURNOVER
--
52 WEEK HIGH
10.59
52 WEEK LOW
1.900
MARKET CAP
8.37M
P/E (TTM)
-0.2476
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CNSP last week (0831-0904)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 5d ago
CNS Pharmaceuticals details business development strategy
TipRanks · 6d ago
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
Barchart · 09/01 08:01
Weekly Report: what happened at CNSP last week (0824-0828)?
Weekly Report · 08/31 10:19
Why Now On-Demand Conference Spotlights Nine Emerging Biotech And Healthcare Stories
NASDAQ · 08/29 10:34
JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs
Barchart · 08/27 08:01
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
Barchart · 08/27 08:01
More
About CNSP
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The Company's drug candidate, Berubicin, is the first anthracycline to appear to cross the blood-brain barrier. Berubicin is the subject of the Company's late-stage, fully-enrolled, global clinical trial for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. The Company's drug candidate, TPI 287, is an abeotaxane which stabilizes microtubules and inhibits cell division, causing apoptosis and cell death. TPI 287 has shown the potential to cross the blood-brain barrier and treat central nervous system (CNS) tumors.

Webull offers CNS Pharmaceuticals Inc stock information, including NASDAQ: CNSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CNSP stock methods without spending real money on the virtual paper trading platform.